Germany· DE-A57-28db4a4c464137cd
Cidofovir Tillomed
A medicinal product containing anhydrous cidofovir, registered in Germany by Tillomed Pharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Anhydrous Cidofovir
- Manufacturer
- Tillomed Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Anhydrous cidofovir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCidofovir 1% in Unguentum M creamSpecial Order
- United StatesCIDOFOVIRMylan Institutional LLC
- CzechiaCIDOFOVIR TILLOMED
- FinlandCidofovir MacureMacure Pharma ApS
- SpainCIDOFOVIR ZENTIVA 75 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFGZentiva K.S.
- BelgiumCidofovir Tillomed 75 mg/mlTillomed Pharma
- FranceCIDOFOVIR TILLOMED 75 mg/mL solution à diluer pour perfusionTILLOMED PHARMA (ALLEMAGNE)
- CanadaMAR-CIDOFOVIRMARCAN PHARMACEUTICALS INC
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Cidofovir Tillomed
- Belgium · Cidofovir Tillomed
- Czechia · Cidofovir Tillomed
- Denmark · Cidofovir Macure
- Spain · Cidofovir Zentiva
- Finland · Cidofovir Macure
- France · Cidofovir Tillomed
- United Kingdom (Northern Ireland) · Cidofovir Tillomed
- Greece · Cidofovir Tillomed
- Ireland · Cidofovir Tillomed
- Italy · Cidofovir Tillomed
- Netherlands · Cidofovir Tillomed
- Norway · Cidofovir Macure
- Poland · Cidofovir Tillomed
- Portugal · Cidofovir Tillomed
- Sweden · Cidofovir Macure
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c2652ec4-7a15-470a-9d50-da00810bfd9a GET /v1/drugs/c2652ec4-7a15-470a-9d50-da00810bfd9a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Anhydrous Cidofovir",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about anhydrous cidofovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.